Jeffrey Knox

Jeffrey Knox is a professional with a diverse background in venture capital, biotechnology, and healthcare. He graduated from MIT Sloan School of Management with an MBA in 2022.23

Currently, Jeffrey works as an Investor at Innospark Ventures, an early-stage venture capital firm that supports founders leveraging AI in life sciences, healthcare, and business services.2 He joined Innospark in February 2022 and focuses on applications of computed intelligence to healthcare and biotechnology.1

Prior to his current role, Jeffrey's experience includes:

1. Co-Managing Director and Lead of Operations at Nucleate Bio, an entrepreneurship organization enabling the formation of life science ventures.2

2. Business Development at Carmine Therapeutics, a biotechnology company developing novel non-viral gene therapies.2

3. Business Development Intern at Takeda's Center for External Innovation.2

4. MBA Intern at Dana-Farber Cancer Institute's Binney Street Capital and Lifespan Equity Partners.2

5. Various roles at TRINITY, a life sciences consultancy, where he worked for about 6 years, progressing from Associate Consultant to Associate Principal.2

Jeffrey holds a BS in Biomedical Engineering from Johns Hopkins University in addition to his MBA from MIT Sloan.1 Outside of work, he enjoys participating in local pickup frisbee games, hiking in New Hampshire, and cooking on weekends.1

His LinkedIn username is jeffrey-knox, as mentioned in the query.